It’s not yet clear whether wearable fitness trackers, such as Fitbits, Jawbones and Microsoft Bands, really do encourage us to become healthier over the longer term. They might make us move more and eat healthier in the first few days of strapping them around our wrists, but how long before the novelty wears off?
From my own experience of using these gadgets for research purposes (over nearly two years now), I must confess that using them is a bit of a chore. Still, when I’m wearing one I use the stairs instead of the lift, park further away from places so I have to walk, and I sit less and eat less. This takes effort and willpower. But, by reaching daily activity targets and measuring my progress, I have improved my body mass index (BMI), I feel healthier and I am fitter. Even when I’m on holiday, I force myself to wear one. Why? Because I am overweight and I am not motivated enough on my own.
My self-experimentation aside, the benefits of using wearable fitness trackers are not well understood yet. That’s maybe because they’ve only been around a few years, so it’s early days in research terms. And while the physical results that individuals experience as a result of wearing them might show promise, the benefits are not necessarily applicable to everyone.
The appeal of wearable fitness trackers, and their cost (they range from tens to hundreds of pounds a piece), mean that current use is largely among the “worried well”, “fitness geeks” or “quantified selves” (people who use technology to track all aspects of their daily lives with the goal of self-improvement). In other words, those who want them rather than need them. But what if these devices could really make us all healthier?
The NHS is already exploring the potential of various innovative approaches to reducing our expanding waistlines. In some areas, financial incentives, free access to dieting clubs or exercise classes are offered to encourage people to address poor diets and inactive lifestyles in the “war on obesity”. Might it be time to investigate the feasibility of wearable fitness trackers, too? Going by my own experience of using them – which is very much self-imposed – I wonder whether widening accessibility might attract and encourage a wider section of society to commit to trackers and reap the same benefits I have.
Obesity is strongly linked with poverty and low educational attainment, so we might assume that many of those at risk would not be your typical fitness tracker consumers. But if fitness trackers were made available through health services, like the other options are, they could have the potential to improve eating habits and increase activity for those who need encouragement most.
The Medical Research Council provides guidance on how to develop and evaluate new strategies to improve health. But these take time and it seems a shame that our health services are not exploiting current trends in self-tracking. The NHS already offers advice on wearable fitness gadgets to potential wearers – why not the devices themselves?
An ounce of prevention
My recent research found that the NHS has started to use new technologies for lifestyle management. But it seems that their use is mostly for people who have already developed chronic health conditions, including type 2 diabetes (which can be linked to obesity), rather than to target disease prevention. Are we missing an opportunity?
There are research gaps around the everyday impacts of using these devices on people’s lives – will they become addicted, will they get tired of self-monitoring – and some concerns about how wearable fitness trackers might negatively affect our relationship with our doctor, for example by replacing face-to-face contact with machine interactions.
There are also issues around information, surveillance and privacy, and the lengths to which, if we use NHS-provided tech, our data might be used against us if we don’t comply with recommendations about healthy living. But, at the moment, these fears could be allayed by the simple offer of a wearable fitness tracker on the same terms as any other prescription.
Heather Morgan's recent work was funded by The Wellcome Trust through the University of Aberdeen’s Institutional Strategic Support Fund under Grant RG12724-13. She is currently employed at the Health Services Research Unit at the University of Aberdeen, which is supported by the Chief Scientist Office (CSO) of the Scottish Government Health and Social Care Directorates.
Heather May Morgan, Research Fellow, University of Aberdeen
This article was originally published on The Conversation. Read the original article.



Kuaishou Stock Jumps as Kling AI Secures $2 Billion Funding Round
Supreme Court Blocks 5th Circuit Ruling on Abortion Pill Access
Organon Stock Surges After Reports of $13 Billion Buyout Bid by Sun Pharma
Goldman Sachs Raises USD/JPY Forecast, Sees Yen Weakness Persist Through 2027
NIH Infectious Disease Leadership Shake-Up Raises Concerns Amid Ebola, Hantavirus Outbreaks
Anthropic Restores Claude Fable 5 and Mythos 5 After U.S. Lifts AI Export Controls
Super Micro Employees Detained in Taiwan AI Server Export Investigation
Vietnam’s population hit the 100 million milestone. Where’s it headed?
Apple Eyes Chinese Memory Chips as AI Shortage Pressures iPhone Supply Chain
GSK Reportedly Nears $9 Billion Acquisition of Cancer Drug Developer Nuvalent
State of emergency in Crimea as Ukraine focuses pressure on ‘jewel in Putin’s crown’
CDC Monitors 41 Americans After Andes Hantavirus Outbreak on Luxury Cruise Ship
Hantavirus Cruise Ship Outbreak Triggers Global Health Alert
Goldman Sachs Flags 3 Key Risks Ahead of Europe’s Earnings Season 



